Stay updated with breaking news from Complete Genomics. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.
BACKGROUND - This month, a Delaware federal jury determined that Illumina, Inc. (Illumina) willfully infringed two DNA sequencing patents owned by Complete Genomics, Inc. (CGI), while...
Because the jury found that Illumina’s infringement was willful, the judge could choose to increase the damages award up to three times that amount and award CGI its reasonable attorney fees.
Delaware federal jury found that Illumina infringed on two patents of Complete Genomics, a U.S. subsidiary of Chinese firm BGI. The San Diego gene sequencing market leader says it will appeal
Biden eyes new ways to bar China from scooping up US data
By Alexandra Alper and Karen Freifeld